Rekovar Joins NVIDIA Inception

We are excited to announce that Rekovar has been accepted into the NVIDIA Inception Program, a platform designed to support groundbreaking startups transforming industries through AI and data science. This recognition marks a significant milestone in our journey to revolutionize care for neonates, particularly those affected by Neonatal Abstinence Syndrome (NAS). 

The NVIDIA Inception Program is known for empowering startups with the tools and resources needed to accelerate innovation. As members, we gain access to:

• AWS credits to bootstrap our cloud infrastructure.

• Expert guidance to refine and deploy our machine learning models.

• Networking opportunities with other pioneering startups and thought leaders in AI and healthcare.

This collaboration with NVIDIA aligns perfectly with our mission to enhance neonatal care through advanced AI-driven solutions. 

Neonatal Abstinence Syndrome affects infants exposed to opioids and other substances during pregnancy, leading to withdrawal symptoms that require intensive care. At Rekovar, we are developing an AI-powered monitoring and scoring device that leverages physiological, neurological, and behavioral biomarkers to:

• Improve the accuracy and consistency of NAS assessments.

• Reduce hospital readmissions and shorten stays.

• Enhance at-home care and optimize therapeutic interventions.

By combining the power of AI with clinical expertise, we aim to create a brighter future for neonates and their families.